Sieckhaus John 4
4 · BioSig Technologies, Inc. · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Sieckhaus John
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-30+92,300→ 92,300 totalExercise: $0.26Exp: 2033-11-30→ Common Stock (92,300 underlying)
Footnotes (1)
- [F1]This stock option fully vested on November 30, 2023, the date of grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.